IFP Advisors, Inc - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 86 filers reported holding REVANCE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.69 and the average weighting 1.4%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$860
-78.8%
75
-50.0%
0.00%
Q2 2023$4,050
-93.2%
150
-92.8%
0.00%
-100.0%
Q1 2023$59,552
+2977500.0%
2,075
+2666.7%
0.00%
Q4 2022$2
-99.9%
75
-10.7%
0.00%
Q3 2022$3,0000.0%840.0%0.00%
Q2 2022$3,000
-50.0%
84
-50.0%
0.00%
Q1 2022$6,000
+500.0%
168
+124.0%
0.00%
Q4 2021$1,000
-97.0%
75
-94.0%
0.00%
-100.0%
Q2 2017$33,000
+57.1%
1,250
+25.0%
0.00%0.0%
Q1 2017$21,0001,000
+14185.7%
0.00%
Q4 2015$070.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders